People

Robert Blazej

Robert Blazej is a biotechnology entrepreneur and investor published as a Mission Bay Capital partner. March2026 Awesome Enablers ADV corroborates Robert Glenn Blazej as principal of the FundIII adviser. He previously directed digital biotechnology and global scouting at Novozymes and co-founded Allopartis Biotechnologies, acquired by Novozymes in2013. His2006 joint UC Berkeley/UCSF bioengineering doctorate focused on microfluidic DNA-sequencing systems. External MBC BioLabs and Mission BioCapital affiliations remain separate.